CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of Medicine to evaluate efficacy and safety of CDI-988 No ...

To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide with more than 685 million infections each year.

The virus can spread easily with around 685 million cases reported a year ...

CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 data and updates from ongoing Phase 1b study conducted ...

Stopping viruses before they strike is a key challenge in public health. A research team led by Associate Professor Li Dan from the Department of Food Science and Technology at National University of ...

Seaweed may be a popular food item, but it has certain properties which have the ability to create a shield within the human body, effectively ...

Viruses such as human norovirus can travel in vesicles, small fluid-filled sacs that are like shipping containers for cells.

The Food and Drug Administration is advising restaurants and food retailers not to serve or sell and to dispose of, and ...

We might be near the end of winter, but the spread of norovirus shows little sign of slowing down. The number of people in hospital with the winter vomiting bug has hit a record h ...

The Food and Drug Administration said the recall involves certain clams and oysters distributed in nine states, including California, Georgia, and Florida.

Levels of virus recorded in last year of February was over twice the median number of cases seen in the same week over the last four years ...